Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 139

Similar articles for PubMed (Select 24193321)

1.

Augmentation of thrombin generation in neonates undergoing cardiopulmonary bypass.

Guzzetta NA, Szlam F, Kiser AS, Fernandez JD, Szlam AD, Leong T, Tanaka KA.

Br J Anaesth. 2014 Feb;112(2):319-27. doi: 10.1093/bja/aet355. Epub 2013 Nov 4.

2.

Evaluation of recombinant activated factor VII, prothrombin complex concentrate, and fibrinogen concentrate to reverse apixaban in a rabbit model of bleeding and thrombosis.

Martin AC, Le Bonniec B, Fischer AM, Marchand-Leroux C, Gaussem P, Samama CM, Godier A.

Int J Cardiol. 2013 Oct 9;168(4):4228-33. doi: 10.1016/j.ijcard.2013.07.152. Epub 2013 Aug 6.

PMID:
23928345
3.

Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass.

Guzzetta NA, Huch S, Fernandez JD, Tosone SR, Miller BE.

Paediatr Anaesth. 2009 Apr;19(4):364-70. doi: 10.1111/j.1460-9592.2008.02905.x. Epub 2008 Dec 30.

PMID:
19143947
4.

Prothrombin complex concentrate versus recombinant factor VIIa for reversal of hemodilutional coagulopathy in a porcine trauma model.

Dickneite G, Dörr B, Kaspereit F, Tanaka KA.

J Trauma. 2010 May;68(5):1151-7. doi: 10.1097/TA.0b013e3181b06364.

PMID:
19996804
5.

Correcting thrombin generation ex vivo using different haemostatic agents following cardiac surgery requiring the use of cardiopulmonary bypass.

Percy CL, Hartmann R, Jones RM, Balachandran S, Mehta D, Dockal M, Scheiflinger F, O'Donnell VB, Hall JE, Collins PW.

Blood Coagul Fibrinolysis. 2015 Jun;26(4):357-67. doi: 10.1097/MBC.0000000000000243.

PMID:
25928274
6.

Evaluation of prothrombin complex concentrate and recombinant activated factor VII to reverse rivaroxaban in a rabbit model.

Godier A, Miclot A, Le Bonniec B, Durand M, Fischer AM, Emmerich J, Marchand-Leroux C, Lecompte T, Samama CM.

Anesthesiology. 2012 Jan;116(1):94-102. doi: 10.1097/ALN.0b013e318238c036.

PMID:
22042412
7.

Improved clot formation by combined administration of activated factor VII (NovoSeven) and fibrinogen (Haemocomplettan P).

Tanaka KA, Taketomi T, Szlam F, Calatzis A, Levy JH.

Anesth Analg. 2008 Mar;106(3):732-8, table of contents. doi: 10.1213/ane.0b013e318163fc76.

PMID:
18292410
8.

Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro.

Perzborn E, Heitmeier S, Laux V, Buchmüller A.

Thromb Res. 2014 Apr;133(4):671-81. doi: 10.1016/j.thromres.2014.01.017. Epub 2014 Jan 21.

9.

Prothrombin complex concentrate mitigates diffuse bleeding after cardiopulmonary bypass in a porcine model.

Kaspereit F, Hoffmann S, Pragst I, Dickneite G.

Br J Anaesth. 2010 Nov;105(5):576-82. doi: 10.1093/bja/aeq216. Epub 2010 Aug 17.

10.

Recombinant activated factor VII and prothrombin complex concentrates have different effects on bleeding and arterial thrombosis in the haemodiluted rabbit.

Le Saché F, Le Bonniec B, Gaussem P, Dizier B, Tagzirt M, Godier A, Emmerich J, Samama CM.

Br J Anaesth. 2012 Apr;108(4):586-93. doi: 10.1093/bja/aer450. Epub 2012 Jan 18.

11.

Levels of prothrombin activation peptide F1+2 in patients with a bleeding tendency.

Ingerslev J, Holm M, Christiansen K, Knudsen L, Négrier C.

Blood Coagul Fibrinolysis. 1998 Mar;9 Suppl 1:S129-34.

PMID:
9819044
12.

Thrombin generation and fibrinolysis in anti-factor IX treated blood and plasma spiked with factor VIII inhibitor bypassing activity or recombinant factor VIIa.

Bolliger D, Szlam F, Molinaro RJ, Escobar MA, Levy JH, Tanaka KA.

Haemophilia. 2010 May;16(3):510-7. doi: 10.1111/j.1365-2516.2009.02164.x. Epub 2009 Dec 29. Erratum in: Haemophilia. 2010 May;16(3):567.

PMID:
20050927
13.

The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.

Pychyńska-Pokorska M, Moll JJ, Krajewski W, Jarosik P.

Pediatr Crit Care Med. 2004 May;5(3):246-50.

PMID:
15115562
14.

Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage.

Le Roux P, Pollack CV Jr, Milan M, Schaefer A.

J Neurosurg. 2014 Aug;121 Suppl:1-20. doi: 10.3171/2014.8.paradigm. Review.

PMID:
25081496
15.

The combination of recombinant factor VIIa and fibrinogen correct clotting ex vivo in patient samples obtained following cardiopulmonary bypass surgery.

Sørensen B, Asvaldsdottir HS, Gudmundsdottir BR, Onundarson PT.

Thromb Res. 2009 Dec;124(6):695-700. doi: 10.1016/j.thromres.2009.08.008. Epub 2009 Sep 4.

PMID:
19733387
16.

Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation.

Tanaka KA, Szlam F, Dickneite G, Levy JH.

Thromb Res. 2008;122(1):117-23. Epub 2007 Oct 31.

PMID:
17977586
17.

Therapeutic correction of thrombin generation in dilution-induced coagulopathy: computational analysis based on a data set of healthy subjects.

Mitrophanov AY, Rosendaal FR, Reifman J.

J Trauma Acute Care Surg. 2012 Aug;73(2 Suppl 1):S95-S102. doi: 10.1097/TA.0b013e3182609bca.

PMID:
22847103
18.

Prothrombin complex concentrate (Beriplex P/N) for control of bleeding after kidney trauma in a rabbit dilutional coagulopathy model.

Pragst I, Kaspereit F, Dörr B, Dickneite G.

Thromb Res. 2010 Mar;125(3):272-7. doi: 10.1016/j.thromres.2009.10.011. Epub 2009 Nov 14.

PMID:
19913880
19.

Influence of cardiopulmonary bypass on the interaction of recombinant factor VIIa with activated platelets.

Kjalke M, Runge M, Rojkjaer R, Steinbruchel D, Johansson PI.

J Extra Corpor Technol. 2009 Jun;41(2):97-104.

PMID:
19681308
20.

Use of recombinant factor VIIa (NovoSeven) in pediatric cardiac surgery.

Niles SD, Burkhart HM, Duffey DA, Buhrman K, Burzynski J, Holt DW.

J Extra Corpor Technol. 2008 Dec;40(4):241-8.

PMID:
19192753
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk